Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Congrats to all the long timers here.
As I always say: "The Best is yet to Be..."
What..?
Thank you Mary...
Lookin forward to it..!
Q3 CALL TODAY! SWEEEEEEEEEEEEEEEEEEET..!!!!!!!!!!!!!!!!
Right you are my friend...
And my favorite line is:
"Revenues increased by 94% over the same month last year and prescriptions filled increased 73%."
Yep... I've noticed that Serb...
If we get anywhere near the dramatic revenue increases we had last time for the month of September I believe we'll be in excellent shape going forward...
Has anyone noticed we have been trading almost double the volume off of the 10 day average? Something is happening here and I'm getting excited!
And the pps could be doubling this month...
Wait for it...
One word... Awesome...
NEWS
Progressive Care Inc. Announces Formation of RXMD Therapeutics Inc. Specializing in Cannabinoid-Based and Alternative Nutraceutical Products
MIAMI, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announces the formation of its wholly owned subsidiary, RXMD Therapeutics Inc., specializing in cannabinoid-based and alternative therapy product lines.
“We are excited to make this official announcement, RXMD Therapeutics Inc. has been in the planning stages this past year” said S. Parikh Mars, CEO of Progressive Care Inc. “We believe we have finally found a pathway where we can provide cannabinoid and homeopathic products that meet our strict quality requirements while also being able to manage these therapies from a health and wellbeing perspective.”
Progressive Care Inc. will develop and produce proprietary cannabinoid and homeopathic products that will be solely offered from RXMD Therapeutics Inc. The first line of production will consist of tinctures, skin creams, roll-ons and gel capsules which are the dosage forms most easily managed by retail patients. RXMD Therapeutics brands will be tested for consistency and quality assurance prior to release and periodically thereafter.
The formation of RXMD Therapeutics Inc. was discussed with Progressive Care Inc.’s shareholders during the first quarter 2019 quarterly report conference call on May 15, 2019. The Company announced plans to market current CBD brands and leverage the cash buying customer base to fortify against insurance rate compression and increase profitability. The Company discussed plans to produce an exclusive line of products that incorporates the Company’s brand and mission to further develop its core market base and healthcare capabilities.
“2019 has moved at an unprecedented pace,” said S. Parikh Mars, CEO of Progressive Care. “In the past 4 months, Progressive Care has doubled in size in almost every measurable way, not only gaining sales, locations, or economies, but a wealth of talent that includes expertise in pharmaceutical logistics, operational management, and clinical awareness. We believe that offering quality natural products is a logical step forward in our development and is consistent with our mission to elevate healthcare.”
For more immediate updates on the company’s media coverage, connect with Progressive Care and PharmCo on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
About RXMD Therapeutics, Inc.
RXMD Therapeutics Inc. is a wholly owned subsidiary of Progressive Care Inc. (OTCQB: RXMD) specializing in cannabinoid-based and alternative nutraceutical products.
$3.7 mil in August...
Each month a new record high...
I pity the sellers...
They still don't seem to have a clue...
Yep... you called it...
And my favorite line is:
"Revenues increased by 94% over the same month last year and prescriptions filled increased 62%..."
Progressive Care Inc. Announces $3.7 Million Gross Revenue for August 2019 MIAMI, FL -- September 24, 2019 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of prescriptions filled for August 2019.
August 2019 sales continued to increase with $3.7 Million in gross revenue and approximately 47,000 prescriptions filled between the 4 locations in Florida. Gross revenue does not include PBM clawbacks for DIR or other fees. Revenues increased by 94% over the same month last year and prescriptions filled increased 62%. These increases are attributable to the acquisition of FPRX in June 2019 as well as organic growth in same store operations.
"The Company continues to excel in the pharmacy industry," said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. "Although we are proud of our overall achievements this year, there is still urgency to do better and realize the true potential of this enterprise. We are focused on delivering innovative solutions to healthcare market and look to capitalize on strategic and transformative relationships."
For more information about Progressive Care, please visit the company's website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long-term care facilities, and health practice risk management.
Yes you are...
RXMD isn't called Progressive for nothing:
BUYS: 37,000
SELLS: 6,000
Well that's good news Jimmy...
All systems are go now...
We are back! North Miami and Davie locations business as usual. Palm beach and Orlando locations will be open tomorrow. https://t.co/gqY707zNDW
This was Tweeted Yesterday Morning!
Thanks Gedi...
I know The Best is yet to Be...
So two new locations opening on Wednesday...
You mean like today Wednesday..?
Yep... True enough...
Conservative price estimate: 9.2 cents per share
$40 mil in annual revenue / 436 mil OS = 9.2 cents
When this thing starts trading closer to its value, we should be right around 10 cents. The CEO has said for awhile that 10 cents is the base price this should be trading at.
With any additional upcoming acquisitions, the PPS should also increase.
Remember, the AS should be increasing here shortly (which I fully support btw), but the OS is unaffected.
Refreshing to get some actual facts here on ONCI...
Expect the green wave to continue well into next month...
$ONCI 2019
Despite a share price in the lower trips, the company is making more money than ever. The Q2 2019 financials (https://backend.otcmarkets.com/otcapi/company/financial-report/223377/content) attest to that, showing nearly 3 million in revenues with the potential for another 3 million more in quarters 3 & 4. Claims of revenues being fake are as fake as the claims being made. With on-time quarterly reports keeping ONCI PINK CURRENT (https://www.otcmarkets.com/stock/ONCI/security), and a registration filing with the SEC showing the exact revenues in the fins (https://ih.advfn.com/stock-market/USOTC/on4-communications-inc-ONCI/stock-news/79455922/registration-a-offering-under-the-securities-act-o), it is prudent to believe the revenues to be 100% accurate and valid.
But what about the A/R? Well, if the revenues were fake, why not fake the A/R as well then? This further shows the revenues to be 100% accurate, validated with an attorney letter (https://backend.otcmarkets.com/otcapi/company/financial-report/217451/content). The growing A/R is not the concern most believe it is. It justifies the fact that business is growing, and that additional revenues are coming in future reports. The more business you do, the higher the A/R. As long as the revenues grow concurrently with the A/R, then there is only future growth to look forward to. ONCI is providing their products with payment terms of 60 to 90 days, not always paid on time. But they WILL be paid, and the revenues WILL continue to grow.
ONCI’s market cap end of today is just over 1 million dollars at $1,059,751. Sheesh people, their revenues are 3 million for the first half of the year, with assets valued at over 10 million. This is ridiculously undervalued. As of the last report, the float is 3,254,427,154 with AS at 5 billion. This balance reflects the recent share reduction of 1.3 billion shares.
Now…what about the product? ONCI now owns more than 50% of Cogosense, which is the bulk of their current business model. The distracted driving apps are constantly being updated, and have been updated to fully comply with the revised requests of our insurance providers. (https://www.otcmarkets.com/stock/ONCI/news/On4-Communications-Inc-Announces-Major-Insurance-Compliance-Milestone-Reached-in-Bringing-Distracted-Driving-Apps-to-Mar?id=230671) The technology here is nothing short of amazing, a hardware/software tandem that allows an admin (parent or fleet owner) to manage and administer every action taking place in the vehicle, from hard braking to speeding to tampering with the hardware. The primary focus is that it stops the driver from using their cell phone while the wheels are in motion. Any parent of a new teen driver can rest easy knowing their child will not be texting and driving. Same applies for the fleet owner—the stats Fleetsafer delivers for just 1 or hundreds of vehicles is pretty awesome. Current fleet clients include Chevron, AT & T, Sprint, and more (https://cogosense.com/distracted-driving/partners). There’s a lot of competition here in the marketplace, proving there’s a growing need for this type of product. But let this be know once and for all—no other competitor’s product owns the Cogosense patent, meaning their products are driver voluntary. ONCI’s product is controlled by the administrator—the parent and the fleet owner.
But this is just the beginning for ONCI. There are other apps in development, such as a child car seat alarm. This man wishes he had one: (https://www.nytimes.com/2019/07/29/nyregion/twins-hot-car-father.html). ONCI products, plain and simple, strive to save lives. That in and of itself is worth a LOT more than .0004.
Now what about Sifthouse Industries? http://sifthouse.com/ (website being built) is a start up MJ Craft Grower in Vancouver who are awaiting a license to begin growing their exclusive proprietary blend. The location has been leased, equipment has been purchased. It’s a waiting game as their registration (https://www.nuans.com/auth/app/scr/corp/nuans/public/PreSearch.html?name=Sifthouse&reportType=&distinctiveTerm=&naics=) is awaiting approval for a license. REMEMBER, this is a START UP. Once the license is granted, it will be full steam ahead into the MJ biz.
Another start-up is giftcardexchange.shop, a giftcard trading site that is being built and populated with retailer giftcards. Again, we’re seeing a delay here but SB is hopeful that the site will be launched in the fall.
CEO Steve Berman is a showman, talks a big game but tends to get caught up in his promises of great things and trips over his own words. Love him or hate him, the guy knows how to sell and build a business. Yep, no question the PPS is where it is because of his missed deadlines and his decisions to change the course of action.
But it is prudent to invest in a business that is being built one step at a time, and not in two-year old missed deadlines and broken promises. It is in my opinion that Steve, like ONCI, is experiencing CEO growing pains. He has learned what to do, and what not to do. I believe we will see less empty promises, and more announcements of substance as ONCI continues to flourish. Sure, revenues rule, but honesty is the best policy. He is being honest and loyal to his clients, promising them to not publicly announce their names. He learned from that mistake and it cost him a million-dollar deal in Nissan Garden City. If I were CEO, I wouldn’t take chances either.
Now it’s time for Steve to be honest with his shareholders.
Right now ONCI’s big fat black eye is the private label ads. Both PL deals exist, Pharrel is a pseudonym for a division of a top 10 insurer that specializes in large machinery. PL 2 is one of the east-coast’s largest dealer groups, soon to become larger with the purchase of a chain in the south. We’ve been told over and over that there are ads for this deal, and he even announced that they are running. Here’s where I stop playing Mrs. Nice Gal and ask our boss: IF THE ADS ARE RUNNING PUBLICY, PLEASE RELEASE ONE. JUST ONE. SHOW YOUR SHAREHOLDERS THAT YOU MEAN BUSINESS. Of course it’s very possible the dealer group has asked Steve not to announce them in a public forum. But truth be told, SB has been touting this deal for a year now and we his shareholders have held on with the hope that one day we will see them. SB—if you want to unlock shareholder value as you said in your last PR, release an ad.
There’s a lot to look forward to here. ONCI is growing and the numbers prove it is absolutely undervalued. ONCI was trading at .0012 three years ago with 55k in revs. Now it’s on target to bring in 6 million in revs this year and it’s at .0004. I have had no problem adding tens of millions here.
With 90 million on the bid, ONCI is ready to make another run. Bank on it.
GLTA
Excellent post holt69...
Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, wishes to remind shareholders of the scheduled shareholder meeting on August 30, 2019.
Thanks for the updates sharpei...
Great call! She's believable. Big things coming! She re-affirms that that common shareholder will make ANY decisions (if/and when!!!) regarding splits. I hope you are all listening; it's great!
Looking at audits for Jan 2020.
Yes, gedi, Mars sounds so clear, knowledgable, totally believable.
She's going into great detail on Cannabis... missing a lot. There should be audios after the conf. for public to call in to hear it all.
Armen is speaking now going into more detail on why they are proceeding slowly w/Cannabis...making certain every I dotted, t's crossed!!!
Armen spoke and add detail: 'We are primarily a pharmacy...Lots of agencies to answer to.
Post by: holt69
NO INCREASE in OS!!!
The loans this company took out (strictly in relation to the acquisitions earlier this year) do not mature for 3 years. This is a big difference between this company (a reputable company with a proven business model) and all of the other BS OTC companies out there. Look up the terms to loans other OTC companies have. They mature in 3 or 6 months! At that point in time, they sell shares to pay off the loan. The lender doesn't give them time to pay off the loan because they know it won't happen. THIS IS VASTLY DIFFERENT THAN THE FUNDING RXMD HAS GOTTEN!
And as a reminder, they are increasing the AS to satisfy the terms of these loans. THERE IS NO PLANNED INCREASE TO THE OS! The company was reporting profits prior to starting its expansion efforts, so it couldn't be more obvious that any losses reported are temporary and only due to additional costs related to the expansions!!! After they obtain SEC compliance in 2020, they will be able to obtain additional private financing for increased expansion efforts and have no problem paying off the loans from earlier this year. Remember, you need to spend money to make money in this industry!
This company trades on the OTCQB and has been compliant with its requirements. That involves having AUDITED annual financial statements. Here's the company that performed the last audit: https://www.bpbcpa.com/. Check out page 41 of the '18 annual report for their auditing opinion (certification): https://backend.otcmarkets.com/otcapi/company/financial-report/215985/content
Any shareholders expecting something good to the upside from the meeting tomorrow..?
Progressive Care Inc. Hosting Shareholder Meeting on August 30, 2019 at Corporate Office in Hallandale Beach, Florida
Press Release | 08/26/2019
MIAMI, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, wishes to remind shareholders of the scheduled shareholder meeting on August 30, 2019 at Progressive Care’s corporate office in Hallandale Beach, FL at 400 Anton Blvd.
This could be BIG...
Progressive Care Inc. Hosting Shareholder Meeting on August 30, 2019 at Corporate Office in Hallandale Beach, Florida
Press Release | 08/26/2019
MIAMI, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, wishes to remind shareholders of the scheduled shareholder meeting on August 30, 2019 at Progressive Care’s corporate office in Hallandale Beach, FL at 400 Anton Blvd.
“Our shareholders are just beginning to get their proxy notices and now is a good time to encourage everyone to ask questions and reach out to us,” stated S. Parikh Mars, CEO of Progressive Care. “We think that spending time speaking directly with shareholders will be beneficial to all of us.”
The Company requests that any individuals intending to attend in person should RSVP so that it can allocate the appropriate resources. The Company wanted to ensure that shareholders understand that the voting item is for the sole purpose of meeting the obligations set forth in the financing agreements. The increase in authorized is not be exhausted upon approval, but rather to facilitate the reserve as set forth in the agreements. According to the agreements, the secured creditor is prohibited from converting more than 9% of the shares issued and outstanding at any given time and must abide by selling restrictions upon conversion. The Company and its insiders and affiliates continue to refrain from engaging in market activities. Any change in that status will be disclosed to shareholders in advance.
RXMD Awesome $$ Progression...
Progressive Care Inc. Reports Record Revenue of $3.4 Million for July 2019 Press Release | 08/21/2019
MIAMI, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced record revenues of approximately $3.4 million for July 2019 and an 73% increase in prescriptions filled at over 46,400 total.
The Company recorded an 88% increase in gross revenues at $3.4 million exclusive of PBM fees and over 46,000 prescriptions filled. The Company has been actively pursuing growth strategies that will enhance our core business. We are currently working to optimize profitability by focusing sales efforts on patients whose medication benefits are managed by PBMs that have sustainable reimbursement rates or do not charge excessive fees.
“We have aggressively pursued sales and prescription growth throughout the year,” said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. “While we feel that growth is in our best interest, it is important that we make gains in the right way. By presenting ourselves to patients enrolled in drug benefit programs that adequately compensate the pharmacy, we will be able to improve our quality of care while also increasing our bottom line.”
For more information about Progressive Care, please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
Next week conference call and July numbers. Hoping they are in the $3.4-$3.5 million range.
(Expecting these reports may well double the current pps. We shall see...)
I see you guys are managing the RXMD board quite well. Little busy here, so keep up the good work and spread the information and DD as it comes in.
Remember submit your questions if you want to know some answers, remember they have discussed Georgia and Northern Florida for potential acquisitions. What more do you want to know about that? What city in GA?
Any plans for further moves North/West. New Orleans?
Open your minds and come up with some good questions to either see what this company has planned, or even to expand managements thoughts to something they may have never considered.
Some RXMD facts worth repeating...
SmallCapVoice Conference Call Highlights with CEO Mars 7/9/19
FSRX Acquisition
Effectively doubled in size, went from 2 locations to 4, which presents a Humongous expansion opportunity. Increased our radius especially in the Orlando area on the I-4 Corridor.
Doing about 50,000 prescriptions a month (30,000 prescriptions through PharmcoRX and 18,000 through FSRX). Goal is to take those 2 new locations to the next level with the marketing and brand awareness.
Should be close to $2.8 to $3.0 million net revenues per month, every month from here on out (June produced $3.3 million in net revenues).
In less than 12 months, have completed two acquisitions, adding 3 locations and we are not stopping there.
Areas of RXMD focus - Big Items
Shareholder Meeting – working on getting venue and announcements
Working on getting Audited Financials for combined company to refile with the SEC.
Working on our CBD line, which navigating the legal hurdles is fairly immense, as a pharmacy a lot more regulation than everyone else in this space.
Have 2 CBD lines that we are offering right now.
Looking at additional expansion. Getting us further North in Florida and possibly Georgia. Going through due diligence package we are working through to see if it is the right deal that is beneficial for us, beneficial to shareholders, and acquired company as well.
It’s going to be BOOM BOOM BOOM through the end of the year.
Updating HQs and making it the flagship
Working directly with some of the best technological companies in the country, both pharmacy and software wise, to make an innovative step above, this is going to be a pharmacy that can handle business that is 3 times the volume we do today..we are prepping for the next 5 years. Going to move all of the Miami facility here in 2020 and likely some if not all of the Davie operation here as well.
So there is a lot going on, and it will be very involved and very fast over the next 12 to 18 months.
Other Services
Diversifying to cash based sales, business to business sales, and technology sales. That’s why we went into Tele-Pharmacy. Which by the way we took to idea share and Tele-pharmacy is now a thing, and we spearheaded it. We are the ones that brought it to the table, and we are seeing the market react to us. When we go to present ourselves now Tele-pharmacy is a legitimate thing. We are developing that technology to have the opportunity to leverage for financial results.
We are also working on how we can do business with Managed Services Organization (MSO)’s (, provides administrative support services to individual physicians and group practices) and physician practices outside of insurance environment that provides them a value add, also 340Bs, so we are insulting ourselves. And because we care we are constantly getting new prescriptions, patients. So even though the reimbursement is down the increases in prescriptions and lives that we manage continues to increase.
Awesome updates Stockforce...
Conversation with Armen:
I called Armen this afternoon and talked with him for about 30 minutes. There are many exciting things, especially their plans on CBD business!
1. Pharmacy alliance to fight PBMs
First, I congratulated him on the company’s great achievements, especially when considering the obnoxious environment that has been caused by the unregulated PBMs throughout the whole country. He said some states have already stood up and sued PBMs to preserve states’ rights to regulate them, such as Ohio, Arkansas and New York etc. But Florida has been quiet on this issue. Armen said Progressive Care recently formed an alliance with some other major independent pharmacies in Florida. They are using their collective power to lobby the state law makers to bring this issue to the state’s attention. He hopes this will help change how PBMs can charge independent pharmacies once regulations are put into place in 2020, or 2021.
2. Shareholder Meeting
The meeting will be held in August, no later than early September. Armen confirmed there will be definitely no RS whatsoever. He said some shareholders prefer digital conference to a traditional shareholder meeting so they don’t have to make a trip to Florida. The company is still considering different options. He also said the company’s transfer agent Clear Trust, LLC. will be at the meeting.
3. FPRx audit and SEC filing
They have started auditing Family Physicians Rx for the fiscal year 2017 and 2018. Once completed, they will immediately file S-1 with SEC. Armen said they actually already started preparing S-1 early this year but had to stop because of the timing of the FPRx acquisition. He’s confident they will complete the SEC registration by the EOY.
4. CBD business
I asked him if there’s any change in state and federal regulations regarding pharmacies doing CBD business. He said there’s still a lot of gaps that need be filled regarding the legal status of CBD, especially for pharmacies. But he emphasized this business will bring HUGE revenue stream to Progressive Care considering the company currently is servicing over 20,000 patients. Then I said maybe they could put their CBD business under a different umbrella that is totally separate from their pharmacy business. Armen said that’s exactly what they are planning to do! This new entity will be still under Progressive Care, but will be independent of Pharmco. They have been in talks with some CBD companies for partnerships/acquision. Their goal is still to push out their own brand of CBD products under the name of this new entity. He stressed again that this new business will become a huge revenue stream for Progressive Care. I asked what’s the time frame they can announce such news. He said it might be before the Shareholder meeting, or after the meeting. But as soon as they have the final deal, we will be the first ones to know.
5. The Benchmark Company
They are still using The Benchmark Company as their financial advisor for SEC registration. Armen has talks with them every month to update them on the company’s progress. Benchmark is ready at any time to help Progressive Care register with SEC.
6. More pharmacy acquisitions
The company’s next acquisition target is going north. It will be in Georgia as Shital mentioned earlier. They have been in talks with that company for quite some time.
7. Stock price
Armen said he truly believes the current stock price should be much higher than 10 cents. The company is currently working on putting more resource to empower their new PR strategies so many many more investors will start to know Progressive Care through this campaign. His goal is to DOUBLE the shareholder base for RXMD through the new PR stratigies.
At the end of the call, he said he’s willing to talk with any investor who wants to call him. So if you have any questions, just call his cell phone. His number is listed on Progressive Care’s website on the top right corner: 786-657-2060.
https://progressivecareus.com/
Going for the 7's today.... tomorrow...
RXMD...KING OF THE OTC..!!!
Right you are Serb...
Revenues will hit all time highs...
Progressive Care Inc. Announces Steady Sales Growth in May
BY GlobeNewswire
— 8:00 AM ET 06/25/2019
MIAMI, June 25, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( RXMD
) , a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of prescriptions filled for May 2019 and a record month for PharmCo revenue in Palm Beach, which increased at 98%.
May 2019 sales have remained solid after April’s record-breaking month. The Company filled nearly 28,500 prescriptions between the 2 locations, an increase of 13% over the same month last year. Progressive Care ( RXMD
recorded over $1.8 million in net revenues exclusive of PBM fees.
“The Company is recording year-over-year growth despite drastic reimbursement contraction and aggressive PBM fees,” said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. ( RXMD
) “We are confident that our efforts to build momentum and market penetration is producing the desired results. We expect to leverage our capabilities and the positive growth trajectory to accelerate our progress once the 2 new locations are properly integrated.”
For more information about Progressive Care ( RXMD
), please visit the company’s website.
Connect and stay in touch with us on social media:
Progressive Care Inc. ( RXMD
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
I believe this weeks report will be a mighty good surprise to the upside...
Ents, based on past performance, the company receives approximately 63 dollars (net revenue) mean average per prescription. In May, they did 28500 prescriptions and the newly acquired entity did approximately 18000 prescriptions. Those numbers jump around some from month to month but its fairly safe to say we did 46000 to 47000 prescriptions for the month of June. With those numbers, the estimate for total monthly revenues should be around 2.9 million.
In the last webcast, the CEO estimated net revenues between 2.8 and 3 million for June. Of course we could get a positive surprise and we could go over 3 million but I like to stay realistic in my expectations.
Well said Integrity...
Admin: Worthy of a stick..?
TEN Reasons Why You Should Be Buying Progressive Care (RXMD) NOW
1- On June 1st 2019 the company doubled it's NET revenues to over $40 million with it's latest successful acqusition of TWO more pharmacies in Florida. The CEO just announced that they will be expanding into to the population dense I-4 corridor of Florida, including Tampa, Orlando and Daytona areas and further acquisitions are projected
2- The CEO announced that monthly revenues are expected to increase a WHOPPING 80% and 40 000 prescriptions PER MONTH are projected to be filled. So far In 2019 every single month the company has continued to post new record revenues
3- The company has received a Best In Class 5 star rating from major insurance carriers and Humana has ranked the company in the TOP 10% in the NATION!
4- The company has one of the healthiest strongest balance sheets around, flush with cash in the bank, millions in assets and no toxic debt and no dilution!
5-The CEO is meeting with institutional investors, moving forward big Wall Street money is going to flow into the stock driving the share price higher as the company prepares to be listed on the NASDAQ
6-Insiders hold a large percentage of shares and they have not sold a single share, they know what's coming! Follow the insiders!
7-The company leads the nation in Tele-Pharmacy expanding it's services into retirement and long term care communities across Florida.
The company also leads the nation in servicing patients once they have been discharged from the hospital working directly with hospitals to monitor the patients progress while also providing home deliveries and updating them on their follow-ups with Primary Care and Specialist physicians.
8- The company is in the forefront in the nation in combating the opioid epidemic by making inhouse compounded drugs making them one of the few providers in the nation that offer customised opioid alternative solutions that will include Cannabidiol (CBD). The company has been featured on CBS news and major trade publications as a leader in this field. The CEO has stated they have been in communication with GW Pharmaceuticals who have the first FDA approved CBD drug.
9-The company employs over 120 people and gives back to the communities they serve. In 2018 the company supported vulnerable high risk populations by processing over $6 million worth of prescriptions for the United States federal government 340B program, this program allows certain non-profits and charitable healthcare institutions to purchase prescription drugs at a discounted rate from the company
10- It is very rare to find a stock like Progressive Care (RXMD) trading at such a low level under 10 cents a share! Progressive Care (RXMD) could be the best stock investment most of us may ever make. It is THE #1 stock to buy right now, easily one of the most undervalued stocks in America. Progressive Care (RXMD) is under the radar, a high integrity growth and value stock being run with a code of ethics using world class best business practices and governance making it one of the best stock investments for 2019.
Progressive Care (RXMD) truly is an amazing value stock that come along once in a blue moon, value investing made Warren Buffett one of the best investors! Value investing entails the fundamental analysis of a company's earnings power versus its current share price. Value investing has made Warren Buffett and many of his colleagues famously rich. Not a bad model to emulate, now is the time to buy shares of Progressive Care (RXMD)
Wouldn't be a bit surprised to see 1 milly+ today especially with what could be another mega record breaking income report on or around the 15th...
I'm with yah Serb...
Excellent updates Jimmy...
I think this is my favorite part:
Should be close to $2.8 to $3.0 million for month, every month from here on out. Within next 10 days or so should be releasing sales for all 4 companies. In less than 12 months, have completed two acquisitions, adding 3 locations and we are not stopping there...
New PROGRESSIVECARE INTERVIEW HIGHLIGHTS, transcripted best I could.
https://www.smallcapvoice.com/7-9-19-smallcapvoice-interview-with-progressive-care-inc-rxmd/
About the FSRX Acquistion
Effectively doubled in size, went from 2 locations to 4,
Humongous expansion opportunity, increased our radius especially in the Orlando area.
Doing about 50,000 prescriptions a month
30,000 prescriptions through PharmcoRX and 18,000 through FSRX
Going to take those 2 new locations to the next level with the marketing and brand awareness.
Provides a wonderful opportunity to expand with a pharmacy that is similar to us.
Should be close to $2.8 to $3.0 million for month, every month from here on out.
Within next 10 days or so should be releasing sales for all 4 companies.
In less than 12 months, have completed two acquisitions, adding 3 locations and we are not stopping there.
Areas of RXMD focus - Big Items
Shareholder Meeting – working on getting venue and announcements
Working of getting Audited Financials and refile with the SEC.
Working on our CBD line, which navigating the legal hurdles is fairly immense, as a pharmacy a lot more regulation than everyone else in this space.
Have 2 CBD lines that we are offering right now.
Looking at additional expansion. Getting us further North in Florida and possibly Georgia. Going through due diligence package we are working through to see if it is the right deal that is beneficial for us, beneficial to shareholders, and acquired company as well.
It’s going to be BOOM BOOM BOOM through the end of the year.
Updating HQs and making it the flagship.
Working directly with some of the best technological companies in the country, both pharmacy and software wise, to make an innovative step above, this is going to be a pharmacy that can handle business that is 3 times the volume we do today..we are prepping for the next 5 years. Going to move all of the Miami facility here in 2020 and likely some if not all of the Davie operation here as well.
So there is a lot going on, and it will be very involved and very fast over the next 12 to 18 months.
A lot of people don’t see what coming, we are always looking 12 months ahead. We know PBMs are going to get worse before they get better w/o legislation. But we will continue to achieve utmost standards to obtain high performance standards and obtain bonuses instead of having to payback money.
Diversifying to cash based sales, business to business sales, and technology sales. That’s why we went into Tele-Pharmacy. Which by the way we took to Idea Share and Tele-pharmacy is now a thing, and we spearheaded it. We are the ones that brought it to the table, and we are seeing the market react to us. When we go to present ourselves now Tele-pharmacy is a legitimate thing. We are developing that technology to have the opportunity to leverage for financial results.
We are also working business with MSO’s, physician practices outside of insurance environment, 340Bs, so we are insulting ourselves. And because we care we are constantly getting new prescriptions, patients. So even though the reimbursement is down the increases in prescriptions and lives that we manage.
Stuart Smith,
Shital, being a public company has its own inherit challenges as you know being the CEO, please take the opportunity right now to address some of the misconceptions regarding the handling of shares by insiders and RXMD staff.
Shital Mars, CEO
I think what is happening is a number of shareholders are looking at volume in stock and getting nervous assuming insiders are trying to take advantage or manipulating and trying to sell shares into the market. And that cannot be anything further from the truth. I have not sold a single share, Armen has not sold a single share, most of our staff still have the stock in certificate form in safes somewhere. So none of the insiders are selling, we also know the shareholders are worried about the derivative, and whether our investment partners are converted or clearing shares for sale into market, which is not happening either. Our investors, and creditors and those that have invested in the company have not converted any of the notes or cleared any stock and haven’t executed any market activity in the stock. So what you are seeing is shareholders themselves who have shares either brief or long time making decisions for themselves, none of the insiders are participating in this activity.
Have a Happy Independence Day Gedi & friends...
Yep... My advise...
Load up by or before Friday...
Current Letter to Shareholders:
(ADMIN: Please sticky...)
On4 Communications, Inc. Announces Update To Shareholders June 2019
NEW YORK, July 01, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- On4 Communications (OTCPINK: ONCI) is pleased to announce the following corporate update from CEO Steve Berman:
BUSINESS
Shareholders, I am happy to report that we had another record quarter with sales up YOY and qtr over qtr. We also achieved major milestones which we will discuss in this letter to shareholders. Not only did sales go up but our costs went down significantly making us more profit per unit sold.
We tried successfully a Facebook and Instagram campaign which netted us real profits immediately. The next campaign starts on Monday, July 15th and we are hoping to expand our campaign to include Twitter as well. Because the internet has worked so well for us we are looking to continue the campaign every month. Facebook as I have said keeps giving us residual revenue even we are not running ads. In addition we reduced the OS by 1.4 billion shares which can be seen in the new Financials.
We are doing everything we can to unlock shareholder value and reducing the OS was a big start. We have also released our new OBD designed for Insurance companies, where we can now do all the Telematics that the insurance companies want as well as save lives.
GRANDSLAM
I have a conference call this week and a meeting in a couple of weeks with 2 insurance companies and have reached out to more. The goal is to get a test running and then we can release a private label product for them.
GIFTCARDEXCHANGE.SHOP
As we have discussed Giftcardexchange.shop is moving very quickly. We have chosen a designer and we are currently looking over various designs, Again the biggest issue is not build out but back end compliance. We have to verify the validity of the card with the retailer and make sure its still valid before we can list on the site. We have also discussed an advertising platform that will give us 2 streams of revenue which is always what I want in every business we are involved with. If we can accomplish this we will get ad revenue from all retailers making this a huge deal.
DENTAL
As I have said in the last Update this is still a viable business for us . I have heard back from all 3 companies who are very interested in this concept. In speaking to the senior care providers I discovered that like medical care dental care is all over the place with costs and fees. Since Mobile dentistry is so new most states don know how to deal with it. The only way to make this work is to provide no cost to the patient. I believe we can make this work and this can be a viable business for us.
PRIVATE LABELS
The 2 private label deals we have done have so far been great. We are meeting with Pharrel in the next 2 weeks to discuss the first mining co opp. The company is very interested in our pricing model and we will be putting together a presentation showing them how they can protect their machines and lower insurance costs especially in 3(rd) world countries. Bfound mobile is ready to go and can be ramped up at a moments notice. The heavy truck business is a huge opportunity and we are moving forward everyday. This is an untapped market and we are the first to be there. The roofing co is on its 3(rd) leg of rollout and we will be done with everything by the end of July.
The pl2 is going amazing. I still have an NDA but many of you have seen the ads as they appeared in NH, MAINE, and PENN. Our first invoice will be paid on July 15 and they have requested another 400 units as they roll out across their footprint. I have been told by the owner of the co that they intend to purchase another group in the south-east with 25 dealerships and that will be going through within the next 3 months.
In addition we are in talks with 5 other companies regarding private label opportunities, 2 in Europe and 3 here in the USA .
SIFTHOUSE
As discussed we have signed a lease for the 5000 sf place on the river in Vancouver. We have also negotiated for an additional 20,000 sf if we need within the next 24 months. In addition we have been approached by various companies who want to franchise our idea all over Canada and especially Germany. Canada is on the forefront of the CBD revolution. The amt of land is limited and we will be one of the players as we roll out CBD oils and other cbd products. This business is about to explode. CVS just announced it will sell cbd oils for health and beauty needs. As big companies get more involved the interest will grow and the demand will exceed supply. In my opinion SIFTHOUSE will be our jewel in the crown over the next couple of years.
SHAREHOLDER VALUE
I have always believed this from day one we should try and find a way to unlock shareholder value. I thought with the share reduction of 1.4 billion shares we would be able to do that . According to my legal team this reduction would be a positive for the stock. I guess they were wrong. That being said we are looking at additional ways to give value back to the company. I have met with 2 German hedge funds who are interested in making an investment in our company. We would not consider anything at less then an .0085 value or higher. We are also looking at a company buyback of shares as well as myself buying shares on the open market. I believe that our company is in an amazing place and I am willing to put my money where my mouth is. We are looking at many different opportunities and we will keep you informed of which one we take. The share price is so under valued here I hope you keep your shares and don't let the bashers and MM steal your stock. Of course these are just some ideas and nothing is set in stone. I will be updating our shareholders if anything moves along or changes.
COMPANY
The company is in a great position to capitalize on new markets. Distracted driving is an epidemic in the world and is only getting bigger. Cannabis is one of the fastest growing businesses led by total legalization in Canada with 10 other countries to follow. We have Private label deals in place and we are creating new revenue streams. We are positioned for the future and will ride the wave. We are now branching out from our original model for the company which was to sell in Dealerships. Our goal if I have learned anything is to be diversified into many different businesses because as technology changes and AI changes the world we will be diversified into 6 different businesses all different and self contained. We are poised to have a great run and be in many different sectors of the economy to create amazing growth. We will discuss many other items in the next shareholder letter.
Forward-Looking Statement
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, as well as statements that include words such as "anticipate," "if," "believe," "plan," "estimate," "expect, " "intend," "may," "could," "should," "will," and other similar expressions are forward-looking statements. All forward-looking statements involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements, as described in our reports filed with the Securities and Exchange Commission, which are available for review at www.sec.gov, to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACT INFORMATION
Contact:
On4 Communications, Inc.
On4Company@gmail.com
(323) 487-0389
> Dow Jones Newswires
Worthwhile sharing:
Buy shares... then lock em in at $1.88 - $2.44 per share as I have done...
PPS could be running in the 8's by end of this week...
10 Reasons Why You Should Be Buying RXMD NOW
1- On June 1st 2019 the company doubled it's NET revenues to over $40 million with it's latest successful acqusition of TWO more pharmacies in Florida. The CEO just announced that they will be expanding into to the population dense I-4 corridor of Florida, including Tampa, Orlando and Daytona areas and further acquisitions are projected
2- The CEO announced that monthly revenues are expected to increase a WHOPPING 80% and 40 000 prescriptions PER MONTH are projected to be filled. So far In 2019 every single month the company has continued to post new record revenues
3- The company has received a Best In Class 5 star rating from major insurance carriers and Humana has ranked the company in the TOP 10% in the NATION!
4- The company has one of the healthiest strongest balance sheets around, flush with cash in the bank, millions in assets and no toxic debt and no dilution!
5-The CEO is meeting with institutional investors, moving forward big Wall Street money is going to flow into the stock driving the share price higher as the company prepares to be listed on the NASDAQ
6-Insiders hold a large percentage of shares and they have not sold a single share, they know what's coming! Follow the insiders!
7-The company leads the nation in Tele-Pharmacy expanding it's services into retirement and long term care communities across Florida.
The company also leads the nation in servicing patients once they have been discharged from the hospital working directly with hospitals to monitor the patients progress while also providing home deliveries and updating them on their follow-ups with Primary Care and Specialist physicians.
8- The company is in the forefront in the nation in combating the opioid epidemic by making inhouse compounded drugs making them one of the few providers in the nation that offer customised opioid alternative solutions that will include Cannabidiol (CBD). The company has been featured on CBS news and major trade publications as a leader in this field. The CEO has stated they have been in communication with GW Pharmaceuticals who have the first FDA approved CBD drug.
9-The company employs over 120 people and gives back to the communities they serve. In 2018 the company supported vulnerable high risk populations by processing over $6 million worth of prescriptions for the United States federal government 340B program, this program allows certain non-profits and charitable healthcare institutions to purchase prescription drugs at a discounted rate from the company
10- It is very rare to find a stock like Progressive Care (RXMD) trading at such a low level under 10 cents a share! Progressive Care (RXMD) could be the best stock investment most of us may ever make. It is THE #1 stock to buy right now, easily one of the most undervalued stocks in America. Progressive Care (RXMD) is under the radar, a high integrity growth and value stock being run with a code of ethics using world class best business practices and governance making it one of the best stock investments for 2019.
Progressive Care (RXMD) truly is an amazing value stock that come along once in a blue moon, value investing made Warren Buffett one of the best investors! Value investing entails the fundamental analysis of a company's earnings power versus its current share price. Value investing has made Warren Buffett and many of his colleagues famously rich. Not a bad model to emulate, now is the time to buy shares of Progressive Care (RXMD)
I've got the same feeling there Serb...
The pps might even double in a single day...
Could be tomorrow... Could be next week...
Progressive Care, Inc CEO Recognized by Forbes as a Unique Leader
MIAMI – April 29, 2019 – InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced that it has garnered media coverage in Forbes in an article titled, A Unique Path Towards Leadership Creates a Unique Leader.
"My unique and non-traditional background helped shape who I am as a leader today," said S. Parikh Mars, CEO of Progressive Care Inc. "My story begins with working three jobs, barely making ends meet. It was through my dedication and determination that I was able to reach the executive position in which I hold today with Progressive Care. I am honored to share my story with Forbes and hope that it inspires female entrepreneurs to pursue their dreams and know that anything is possible with determination and hardwork."
In the article titled A Unique Path Towards Leadership Creates a Unique Leader, published April 25, 2019 in Forbes, Mars speaks on her path to CEO of Progressive Care, her perspective on skill development and cultivation, and why without her finance team, she be "flying blind." Shital explains, "A lot of my strength and confidence have come from learning the business from the ground up. Because I know the ins and out of the operation and I know what it's like to do the jobs my employees are doing, I think they relate to me better and respect me more. It also helps me make practical and actionable decisions."
Mars speaks on how her background has influenced her approach in recruitment and skill development at Progressive Care. "The skills I most look for from my finance team are an ability to understand fine details, do critical thinking and problem-solving, and resourcefulness. Of course, a strong understanding of account and math is a must, but at the end of the day, I need a group of people who not only can give me a number but can also tell me what that number means and why that number matters. I look for candidates who ask questions, who show curiosity, not just about the nuts and bolts of the job, but about the company and how it works."
In the article, Mars explains her advocation for women in leadership positions and how she champions other women within her team at Progressive Care. "One of the things I have tried to do in my company is value productivity, not in the number of hours worked, but in the effectiveness of those hours worked. Women, especially those with families and children, often cannot stay late at work to get face time with the boss. It can be difficult to prove your dedication and competence when you have to do it after hours. I don't want to be someone that expects others to make certain sacrifices just because I had to, so I don't judge my employees for leaving work to be with their families. Those things don't make me think they don't love their job or don't care about the company."
Mars further explains in the article her relationship with the Progressive Care CFO, Alan Weisberg, and the value of closely aligning business strategy in finance in addition to what is next for Progressive Care.
The recent media coverage comes after the company's efforts to provide its network with more healthcare informational resources through PharmCo Pharmacy. Additional commentary from Progressive Care's CEO about the company and industry as a whole can be found on the Progressive Care blog and PharmCo blog.
Sounding good Spuds...
That is good news... Thank you Serb..!
And June numbers could be HUGE because..?
When do you think we'll break out of the 6's my friend..?
Wowsers... Nice find there Jimmy...
$RXMD THE NEXT RITE-AID | Check THIS ONE OUT
ProgressiveCare NEWS: Quote:
Progressive Care Inc. Completes Acquisition of Family Physicians RX
MIAMI – June 4, 2019 -- InvestorsHub NewsWire -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, announced today that it has closed on the acquisition of Family Physicians RX, Inc.,dba Five Star RX and Florida corporation (FSRX) on June 1, 2019.
The consummation of the acquisition allows for the Company to begin consolidating financial results from FSRX occurring after June 1st into disclosure reports and news releases. In the month prior to closing, FSRX filled approximately 18,000 prescriptions servicing 7,500 patients. With the addition of the Davie, FL and Orlando locations, Progressive Care now boasts 4 physical pharmacy locations with 5 star performance ratings and nearly 125 employees from which to launch further expansion and sales growth.
"This is our biggest accomplishment to date," said S. Parikh Mars, CEO of Progressive Care. "Now that FSRX is part of the Progressive Care family of pharmacies, we can focus on getting to next level as an organization. I am honored to have this group of talented individuals join our team and to take our collective strength to bring about change and results in this industry."
OH MY, HOW RXMD HAS GROWN UP OVER THE YEARS
RXMD Revenues and Scripts per location, Second to None
RXMD Compared to the Competition WOWSERS!!!
Penny Stock Exempt with low Share Structure
RXMD Retail Stores Commence Major Expansion Across Florida
RXMD 5 Star Humana Rating Earns Them Highest Payout
CEO IS PRETTY, and REALLY SMART
Progressive Care, Inc CEO Recognized by Forbes as a Unique Leader
https://www.forbes.com/sites/jeffthomson/2019/04/25/a-unique-path-towards-leadership-creates-a-unique-leader/#6ee28a593616
PHARMCORX HAS SMARTPACK, EXACT SAME AS PILLPACK
3 YEARS AUDITED F/S
IMPROVED FUNDING AGREEMENTS FOR ACQUISITIONS and NEW HEADQUARTERS
HINT HINT!!! RXMD SERVICE PROVIDERS
RXMD Price Target, prior to any acquisitions. HINT HINT
Yeppers...
Looking good again for RXMD...
Progressive Care Inc. Announces Steady Sales Growth in May
MIAMI, June 25, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of prescriptions filled for May 2019 and a record month for PharmCo revenue in Palm Beach, which increased at 98%.
May 2019 sales have remained solid after April's record-breaking month. The Company filled nearly 28,500 prescriptions between the 2 locations, an increase of 13% over the same month last year. Progressive Care recorded over $1.8 million in net revenues exclusive of PBM fees.
"The Company is recording year-over-year growth despite drastic reimbursement contraction and aggressive PBM fees," said S. Parikh Mars, Chief Executive Officer of Progressive Care Inc. "We are confident that our efforts to build momentum and market penetration is producing the desired results. We expect to leverage our capabilities and the positive growth trajectory to accelerate our progress once the 2 new locations are properly integrated."
For more information about Progressive Care, please visit the company's website.
Connect and stay in touch with us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx